Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective | Zendy

Roman Fleck | Zendy; Daniel Q. Bach | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective

Author(s) -

Roman Fleck,

Daniel Q. Bach

Publication year - 2012

Publication title -

journal of personalized medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.254

H-Index - 27

ISSN - 2075-4426

DOI - 10.3390/jpm2010015

Subject(s) - personalized medicine , perspective (graphical) , biopharmaceutical , field (mathematics) , precision medicine , cancer drugs , venture capital , medicine , engineering ethics , business , cancer , bioinformatics , computer science , engineering , microbiology and biotechnology , pathology , finance , biology , mathematics , artificial intelligence , pure mathematics

Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects. Like most industries, the biopharmaceutical industry is also following certain global trends and these are analyzed in this article. As academia and industry are mutually dependent on each other, researchers in the field should be aware of those trends and the immediate consequences for their research. It is important for the future of this field that there is a healthy relationship among all interested parties as the challenges of personalized medicine are becoming ever more complex.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research